merged_exthera-cancer-blood-filtering-device.txt
<question_number>1</question_number>
<answer>patients bleeding from catheter wounds and screaming in pain</answer>
<question_number>2</question_number>
<answer>Elimination of circulating tumor cells to free up the immune system</answer>
<question_number>3</question_number>
<answer>N/A</answer>
<question_number>4</question_number>
<answer>Use of unsterilized surgical scissors during catheter insertion</answer>
<question_number>5</question_number>
<answer>N/A</answer>
<question_number>6</question_number>
<answer>Conducting treatments in Antigua, where the FDA has no jurisdiction</answer>
<question_number>7</question_number>
<answer>tumor lysis syndrome</answer>
<question_number>8</question_number>
<answer>71 percent</answer>
<question_number>9</question_number>
<answer>three</answer>
<question_number>10</question_number>
<answer>Seraph 100 Microbind Affinity Blood Filter</answer>
<question_number>11</question_number>
<answer>Food and Drug Administration</answer>
<question_number>12</question_number>
<answer>the valve on one of the oxygen tanks</answer>
<question_number>13</question_number>
<answer>two months</answer>
<question_number>14</question_number>
<answer>heparin</answer>
<question_number>15</question_number>
<answer>$10 million</answer>
<question_number>16</question_number>
<answer>dialysis machine</answer>
<question_number>17</question_number>
<answer>five</answer>